WCN23-1154 TRIAL IN PROGRESS: AN OPEN-LABEL, PHASE 2 STUDY TO EVALUATE EFFICACY, SAFETY, PK, PD OF KP104, A BIFUNCTIONAL COMPLEMENT INHIBITOR, IN IGAN AND C3G SUBJECTS
Kidney International Reports(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要